drugset
drugset / Trial / NCT04627207

A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers

NCT04627207 ↗

Phase 1 Unknown 51 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to evaluate the safety and pharmacokinetic characteristics of CKD-333 or Co-administration of CKD-333 and D085 in healthy volunteers

Timeline

Start
2020-11
Primary completion
2021-03
Completion
2021-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg Oral
Subject Atorvastatin Small molecule 20 mg Oral
Subject Candesartan cilexetil Unknown 16 mg Oral

Indications

cardiovascular disorder